WO1998048040A1 - Procede de preparation d'acetals de l-allysine - Google Patents
Procede de preparation d'acetals de l-allysine Download PDFInfo
- Publication number
- WO1998048040A1 WO1998048040A1 PCT/JP1998/001830 JP9801830W WO9848040A1 WO 1998048040 A1 WO1998048040 A1 WO 1998048040A1 JP 9801830 W JP9801830 W JP 9801830W WO 9848040 A1 WO9848040 A1 WO 9848040A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acetal
- producing
- allysine
- general formula
- arlysine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
Definitions
- the present invention relates to a method for producing L-allidine ethyl acetal, and more particularly, to a method for producing L-allidine ethylene acetal.
- L-Arridyne ethyl acetal is useful as a synthetic intermediate in the synthesis of pharmaceuticals. Background art
- an object of the present invention is to provide a method for producing an L-arylidine acetal in a short process and efficiently.
- the present invention provides the following general formula (1):
- R 1 and R 2 are the same or different and each represent an alkyl group having 1 to 8 carbon atoms, or form an alkyl group having 2 to 8 carbon atoms by joining together to form a ring. Represents a group.
- the D, L-allysine acetal used in the present invention is a compound represented by the following general formula (1).
- R ′ and R 2 are the same or different and each represent an alkyl group having 1 to 8 carbon atoms, or R 1 and R 2 2 forms a ring and represents an alkylene group having 2 to 8 carbon atoms.
- the alkyl group is not particularly limited and includes, for example, methyl group, ethyl group, propyl group, isopropyl group, n-butyl group, isobutyl group, t-butyl group, s-butyl group, hexyl group, octyl group And lower alkyl groups such as a group.
- the alkylene group is not particularly limited, and examples thereof include a lower alkylene group such as an ethylene group, a trimethylene group, a tetramethylene group, an ethylethylene group, a butylethylene group, and a hexylethylene group.
- a lower alkylene group such as an ethylene group, a trimethylene group, a tetramethylene group, an ethylethylene group, a butylethylene group, and a hexylethylene group.
- D, L-allylidine ethylene acetal in which R 1 and R 2 are ethylene groups is preferably used.
- the D, L-arsine acetal represented by the above general formula (1) is, for example, a bioorganic & medicinalch emstry. According to the method proposed in 9, 1237 (1995), it can be synthesized in eight steps from commercially available dihydropyran.
- glutaraldehyde monoethylene acetal was synthesized from commercially available dartal aldehyde and ethylene glycol, Furthermore, the glutaraldehyde monoethylen acetal can be easily synthesized by reacting it with hydrocyanic acid and ammonium carbonate by the well-known Bucherer method, followed by hydrolysis.
- the enzyme having the activity of stereoselectively oxidatively deaminating a D-amino acid used in the present invention is not particularly limited, and those obtained from various materials can be used.
- microorganisms belonging to the genus Trigonopsis And D-amino acid oxidase derived from pig kidney and the like examples include, for example, "D-AOD immo bilized” (manufactured by Behringer's Mannheim), and the D-amino acid oxidase derived from the pig kidney.
- D-AOD immo bilized manufactured by Behringer's Mannheim
- D-amino acid oxidase derived from the pig kidney As an example, "D_amino acid oxidase” (manufactured by Sigma) and the like can be mentioned.
- the method for producing an L-arylpyridine acetal of the present invention can be performed, for example, as follows.
- D L-Allysine acetal is used at a substrate concentration of 0.1 to 50 wZv%, preferably 1 to 20%, pH 5 to 10, preferably pH 6 to 9, 1 mM to 1 M, preferably Is dissolved in a buffer solution having a concentration of 10 mM to 100 mM, and D, L-gallicin acetal is added in a weight of 0.001 to 10 times, preferably 0.01 to 2 times the weight of D. - an amino acid Okishidaze added, the reaction temperature.
- D C preferably, carried out at 1 0-5 0 ° C from 1 to 1 0 0 hour, preferably from 1 to 2 0 hours mixing and agitation, D
- An oxidative deamination reaction is performed in a body-selective manner. After completion of the above reaction, the D-amino acid oxidase is recovered and removed by filtration, centrifugation, etc., and then the purified L-algalidine acetal is collected by crystallization or the like.
- the buffer is not particularly limited, and examples thereof include a phosphate buffer.
- the crystallization solvent is not particularly limited, and examples thereof include alcohol solvents such as methanol, ethanol, and propanol; water; and mixed solvent systems thereof.
- hydrogen peroxide is usually produced as a by-product because molecular oxygen is a hydrogen acceptor of D-amino acid oxidase.
- the accumulation of hydrogen peroxide is known to inactivate enzymes and also causes the degradation of 2-oxo-6.6-dialkoxyhexanoic acids.
- Hydrogen peroxide produced in such D-amino acid oxidase catalyzed steps can be removed by any of several methods known to those skilled in the art.
- the first is the use of the enzyme catalase. That is, in the method for producing L-arginine acetal of the present invention, the reaction is carried out in the presence of catalase. Thus, it is possible to catalyze the disproportionation of hydrogen peroxide to molecular oxygen and water.
- catalase is commercially available from mammalian liver, Aspergillus niger, and the like.
- the second method is to use metal oxides. That is, in the method for producing an L-allysine acetal of the present invention, by performing the reaction in the presence of a metal oxide, the water peroxide can be decomposed.
- the metal oxides are not particularly limited, and include, for example, manganese oxides such as manganese dioxide. Since the manganese oxides have an effect of stabilizing enzymes such as D-amino acid oxidase and lipase, they are preferably used, and in the present invention, the D-amino acids are stereoselectively oxidatively deaminated.
- the enzyme having the activity of converting into catalase and the above-mentioned catalase can be used as a whole cell, a crude cell decomposed product, a partially purified enzyme, a purified enzyme, and the like containing these. Further, it may be used as it is, or may be used after being fixed.
- Example 1
- L-arlysine acetal of the present invention Since the method for producing L-arlysine acetal of the present invention is as described above, L-arlysine acetal can be efficiently produced in a short process.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98917612A EP0919630A4 (en) | 1997-04-22 | 1998-04-22 | Process for the preparation of L-allysine acetals |
US09/202,901 US6174707B1 (en) | 1997-04-22 | 1998-04-22 | Process for producing L-allysine acetals |
CA002256894A CA2256894A1 (en) | 1997-04-22 | 1998-04-22 | Process for producing l-allysine acetals |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9/120341 | 1997-04-22 | ||
JP9120341A JPH10295392A (ja) | 1997-04-22 | 1997-04-22 | L−アルリジンアセタールの製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998048040A1 true WO1998048040A1 (fr) | 1998-10-29 |
Family
ID=14783856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1998/001830 WO1998048040A1 (fr) | 1997-04-22 | 1998-04-22 | Procede de preparation d'acetals de l-allysine |
Country Status (5)
Country | Link |
---|---|
US (1) | US6174707B1 (ja) |
EP (1) | EP0919630A4 (ja) |
JP (1) | JPH10295392A (ja) |
CA (1) | CA2256894A1 (ja) |
WO (1) | WO1998048040A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6140088A (en) * | 1998-07-15 | 2000-10-31 | Bristol-Myers Squibb Company | Stereoselective reductive amination of ketones |
US6166227A (en) * | 1998-07-15 | 2000-12-26 | Bristol-Myers Squibb Co. | Preparation of (S)-2-amino-6, 6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
US6468781B1 (en) | 1999-07-08 | 2002-10-22 | Bristol-Myers Squibb Company | Stereoselective reductive amination of ketones |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1007113C2 (nl) † | 1997-09-25 | 1999-03-26 | Dsm Nv | Werkwijze voor de bereiding van optisch actieve 2-amino-omega- oxoalkaanzuurderivaten. |
US6620600B2 (en) * | 2000-09-15 | 2003-09-16 | Bristol-Myers Squibb Co. | Enzymatic resolution of aryl and thio-substituted acids |
DE10155065A1 (de) * | 2001-11-09 | 2003-05-22 | Degussa | Verfahren zur Kristallisation von Oxonorleucinacetal |
DE10337614A1 (de) * | 2003-08-16 | 2005-03-17 | Degussa Ag | Verfahren zur Herstellung von D-Aminosäuren |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS543059A (en) * | 1977-06-06 | 1979-01-11 | Ajinomoto Co Inc | Preparation of tryptophane |
JPS57114587A (en) * | 1980-11-15 | 1982-07-16 | Degussa | Cyclic acetal of glutamic acid-gamma- semialdehyde and manufacture |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62262994A (ja) * | 1986-05-12 | 1987-11-16 | Asahi Chem Ind Co Ltd | D−アミノ酸オキシダ−ゼ遺伝子 |
JPS6363377A (ja) * | 1986-09-02 | 1988-03-19 | Nippon Soda Co Ltd | シユウドモナス属ns303菌及びl−アミノ酸の製法 |
IT1247964B (it) * | 1991-06-03 | 1995-01-05 | Ministero Dell Uni E Della | Processo per la preparazione enzimatica di derivati cefalosporanici |
-
1997
- 1997-04-22 JP JP9120341A patent/JPH10295392A/ja active Pending
-
1998
- 1998-04-22 US US09/202,901 patent/US6174707B1/en not_active Expired - Fee Related
- 1998-04-22 EP EP98917612A patent/EP0919630A4/en not_active Withdrawn
- 1998-04-22 WO PCT/JP1998/001830 patent/WO1998048040A1/ja not_active Application Discontinuation
- 1998-04-22 CA CA002256894A patent/CA2256894A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS543059A (en) * | 1977-06-06 | 1979-01-11 | Ajinomoto Co Inc | Preparation of tryptophane |
JPS57114587A (en) * | 1980-11-15 | 1982-07-16 | Degussa | Cyclic acetal of glutamic acid-gamma- semialdehyde and manufacture |
Non-Patent Citations (6)
Title |
---|
"CATALASE HYDROGEN-PEROXIDE : HYDROGEN-PEROXIDE OXIDOREDUCTASE", ENZYME HANDBOOK, SN, JP, 10 October 1995 (1995-10-10), JP, pages 158, XP002917118 * |
"D-AMINO-ACID OXIDASE D-AMINO-ACID : OXYGEN OXIDOREDUCTASE (DEAMINATING)", ENZYME HANDBOOK, SN, JP, 10 October 1995 (1995-10-10), JP, pages 116, XP002917117 * |
"ENCYCLOPAEDIA CHIMICA 2", ENCYCLOPAEDIA CHIMICA, XX, XX, 15 March 1969 (1969-03-15), XX, pages 364/365, XP002917119 * |
ERO H, EGUCHI C, KAGAWA T: "PRODUCTION OF L-TRYPTOPHAN FROM ALPHA-GLUTAMALDEHYDIC ACID", BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, CHEMICAL SOCIETY OF JAPAN, TOKYO., JP, vol. 62, no. 03, 1 January 1989 (1989-01-01), JP, pages 961 - 963, XP002917120, ISSN: 0009-2673 * |
RUMBERO A, ET AL.: "CHEMICAL SYNTHESIS OF ALLYSINE ETHYLENE ACETAL AND CONVERSION IN SITU INTO 1-PIPERIDEINE-6-CARBOXYLIC ACID: KEY INTERMEDIATE OF THE ALPHA-AMINOADIPIC ACID FOR BETA-LACTAM ANTIBIOTICS BIOSYNTHESIS", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 03, no. 09, 1 January 1995 (1995-01-01), GB, pages 1237 - 1240, XP002917116, ISSN: 0968-0896, DOI: 10.1016/0968-0896(95)00110-3 * |
See also references of EP0919630A4 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6140088A (en) * | 1998-07-15 | 2000-10-31 | Bristol-Myers Squibb Company | Stereoselective reductive amination of ketones |
US6166227A (en) * | 1998-07-15 | 2000-12-26 | Bristol-Myers Squibb Co. | Preparation of (S)-2-amino-6, 6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
US6248882B1 (en) | 1998-07-15 | 2001-06-19 | Bristol-Myers Squibb Co. | Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
US6329542B1 (en) | 1998-07-15 | 2001-12-11 | Bristol-Myers Squibb Co. | Preparation of (S)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
US6486331B2 (en) | 1998-07-15 | 2002-11-26 | Bristol-Myers Squibb Co. | Substituted alkylketo compounds and process |
US6468781B1 (en) | 1999-07-08 | 2002-10-22 | Bristol-Myers Squibb Company | Stereoselective reductive amination of ketones |
Also Published As
Publication number | Publication date |
---|---|
US6174707B1 (en) | 2001-01-16 |
JPH10295392A (ja) | 1998-11-10 |
EP0919630A1 (en) | 1999-06-02 |
EP0919630A4 (en) | 2002-08-28 |
CA2256894A1 (en) | 1998-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0206436A2 (en) | Enzymatic production of optical isomers of 2-halopropionic acids | |
WO1998048040A1 (fr) | Procede de preparation d'acetals de l-allysine | |
US20090030210A1 (en) | Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production | |
US4743547A (en) | Method of producing L-phenylalanine | |
EP0222561B1 (en) | Process for enzymatic separation of optical isomers of 2-aminobutanol | |
JP3941184B2 (ja) | 光学活性1−アシロキシ−3−クロロ−2−プロパノール、及び光学活性3−クロロ−1,2−プロパンジオールの製造法 | |
US5773240A (en) | Optically active α-substituted carboxylic acid derivatives and method for producing the same | |
JP3819082B2 (ja) | 光学活性3−n置換アミノイソ酪酸類およびその塩ならびにそれらの製造方法 | |
JP3704719B2 (ja) | 光学活性3−アミノブタン酸の製造法及びそのエステル中間体 | |
EP0198397B1 (en) | Method of producing l-phenylalanine | |
US5011775A (en) | Enzymatic process for the preparation of rosmarinic acid | |
JP3732535B2 (ja) | 光学活性α−メチルアルカンジカルボン酸−ω−モノエステル及びその対掌体ジエステルを製造する方法 | |
JP3217301B2 (ja) | 光学活性グリシド酸エステル及び光学活性グリセリン酸エステルの製造方法 | |
JP4476963B2 (ja) | 光学活性3−n置換アミノイソ酪酸類およびその塩ならびにそれらの製造方法 | |
JP3024361B2 (ja) | 光学活性ピロリジン類の製造法 | |
JP4834208B2 (ja) | (2s,3r)−2,3−エポキシ酪酸エステルの製造法 | |
EP0396447A1 (fr) | Procédé de séparation énantiomériquement sélective des esters des acides halogéno-2 propioniques | |
JPH03254694A (ja) | 光学活性な含フッ素アルコールの製造方法 | |
JP3970898B2 (ja) | 光学活性α−メチルアルカンジカルボン酸−ω−モノエステル及びその対掌体ジエステルを製造する方法 | |
JPS6222599A (ja) | 光学活性カルボン酸の製造法 | |
WO2004007741A1 (ja) | 光学活性β−アミノニトリル化合物及びその対掌体アミド化合物の製造方法 | |
JPH0615486B2 (ja) | 光学活性な4―ヒドロキシ―2―シクロペンテノン類の製造方法 | |
JPH02240045A (ja) | 光学活性な4―ヒドロキシ―2―シクロペンテノン類の分離法 | |
JPH0733352B2 (ja) | 光学活性な2−置換−4−ヒドロキシ−2−シクロペンテノン類の製造方法 | |
JPH01135749A (ja) | 2種のジアステレオマーn−アシル−アミノ酸エステルを含むジアステレオマー混合物の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref document number: 2256894 Country of ref document: CA Ref country code: CA Ref document number: 2256894 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998917612 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09202901 Country of ref document: US |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1998917612 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998917612 Country of ref document: EP |